Evidence map›Paper›PMID 31034767›Full record

ArticleCurrent protocols in immunology2019

Peptide:MHCII Tetramer-Based Cell Enrichment for the Study of Epitope-Specific CD4

Dmitri I Kotov, Marc K Jenkins

Abstract read
In one paragraph

Article in Current protocols in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PD-1 and CD73 on naive CD4Nature immunology · 2025
    Article
  6. A review of CD4Veterinary immunology and immunopathology · 2024
    Review
  7. Aire mediates tolerance to insulin through thymic trimming of high-affinity T cell clones.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dmitri I KotovDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota.
Marc K JenkinsDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Type I interferons in tolerance in the steady stateP01AI035296 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HOGQUIST, KRISTIN A. · 1993 to 2023
$31.1M
TRACKING CD4+ MEMORY T CELLS IN VIVOR01AI039614 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JENKINS, MARC KEVIN · 1996 to 2023
$8.7M
IMMUNOLOGY TRAINING PROGRAMT32AI007313 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Carla Rothlin · 1989 to 2026
$5.7M
Minnesota Training Program in VirologyT32AI083196 · NIAID · UNIVERSITY OF MINNESOTA · PI Louis M Mansky · 2010 to 2026
$3.2M
NCI NIH HHS P30 CA077598NIAID NIH HHS P01 AI035296NIAID NIH HHS R01 AI039614NIAID NIH HHS T32 AI007313NIAID NIH HHS T32 AI083196
6 · The paper itself

Abstract

Epitope-specific CD4

Indexed as

CD4-Positive T-LymphocytesEpitopes, T-LymphocyteHistocompatibility Antigens Class IIPeptidesAnimalsFlow CytometryMiceEpitopes, T-LymphocyteHistocompatibility Antigens Class IIPeptidesCD4+ T cellsepitope specificmagnetic-bead enrichmentnaive CD4+ T cells

Identifiers

PMID31034767
PMCPMC6570544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.